NAD Metabolism Drives CTCF-Cohesin Chromatin Regulation in EBV-Transformed B-Cells

Chromatin architecture regulates gene expression, and it is maintained by architectural proteins such as CTCF and the cohesin complex. In Epstein Barr virus infected cells, viral chromatin organization is stabilized through the interaction between PARP1 and CTCF, ensuring maintenance of latent gene expression. EBV⁺ B cells exhibit elevated PARP1 activity, which imposes a substantial metabolic burden due to NAD⁺ consumption by PARP1 itself. We demonstrate that efficient EBV infection and B-cell transformation rely on the NAD salvage pathway to sustain PARP1 activity and CTCF and cohesin chromatin folding. Pharmacologic inhibition of the rate-limiting enzyme NAMPT with FK866 phenocopies the chromatin architectural disruption induced by PARP1 and changes in NAD levels affects CTCF/cohesin chromatin architectural remodeling and loop extrusion. Moreover, NAMPT inhibition reduces tumor burden in EBV⁺ xenograft models. These findings identify a critical metabolic dependency linking NAD⁺ homeostasis to CTCF-cohesin mediated chromatin architecture and reveal a therapeutic vulnerability in EBV-associated malignancies.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-02
DOI
https://doi.org/10.64898/2026.11.01.763250
Primary Topic
Genomics and Chromatin Dynamics
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

NAD Metabolism Drives CTCF-Cohesin Chromatin Regulation in EBV-Transformed B-Cells

Lisa Beatrice Caruso, Italo Tempera, Yifei Liao, Samantha S. Soldan et al.
bioRxiv (Cold Spring Harbor Laboratory)
Genomics and Chromatin Dynamics
preprint

NAD Metabolism Drives CTCF-Cohesin Chromatin Regulation in EBV-Transformed B-Cells

Lisa Beatrice Caruso, Italo Tempera, Yifei Liao, Samantha S. Soldan, Andrew V. Kossenkov, Rachel Sklutuis, Giorgia Napoletani, Simone Sidoli, Aaron R. Goldman, Paul M. Lieberman, Davide Maestri, Benjamin E. Gewurz, Laura Corveleyn, Sarah Preston‐Alp, Hsin-Yao Tang, Pyounghwa Park, Wujuan Zhang, Martina Gatto, Lauren Melick
preprint en

Abstract

Chromatin architecture regulates gene expression, and it is maintained by architectural proteins such as CTCF and the cohesin complex. In Epstein Barr virus infected cells, viral chromatin organization is stabilized through the interaction between PARP1 and CTCF, ensuring maintenance of latent gene expression. EBV⁺ B cells exhibit elevated PARP1 activity, which imposes a substantial metabolic burden due to NAD⁺ consumption by PARP1 itself. We demonstrate that efficient EBV infection and B-cell transformation rely on the NAD salvage pathway to sustain PARP1 activity and CTCF and cohesin chromatin folding. Pharmacologic inhibition of the rate-limiting enzyme NAMPT with FK866 phenocopies the chromatin architectural disruption induced by PARP1 and changes in NAD levels affects CTCF/cohesin chromatin architectural remodeling and loop extrusion. Moreover, NAMPT inhibition reduces tumor burden in EBV⁺ xenograft models. These findings identify a critical metabolic dependency linking NAD⁺ homeostasis to CTCF-cohesin mediated chromatin architecture and reveal a therapeutic vulnerability in EBV-associated malignancies.

bioRxiv (Cold Spring Harbor Laboratory)
The Wistar Institute (US), Broad Institute (US), Brigham and Women's Hospital (US), Albert Einstein College of Medicine (US), Harvard University (US), Massachusetts Institute of Technology (US)
Good health and well-being
Genomics and Chromatin Dynamics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon